OWCP (OWC Pharmaceutical Research) Retained Earnings: $-23.43 Mil (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OWC Pharmaceutical Research Retained Earnings?

OWC Pharmaceutical Research OWCP Retained Earnings is $-23.43 Mil as of Sep. 2019.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. OWC Pharmaceutical Research's retained earnings for the quarter that ended in Sep. 2019 was $-23.43 Mil.

OWC Pharmaceutical Research's quarterly retained earnings increased from Mar. 2019 ($-29.28 Mil) to Jun. 2019 ($-22.38 Mil) but then declined from Jun. 2019 ($-22.38 Mil) to Sep. 2019 ($-23.43 Mil).

OWC Pharmaceutical Research's annual retained earnings declined from Dec. 2016 ($-9.96 Mil) to Dec. 2017 ($-14.52 Mil) and declined from Dec. 2017 ($-14.52 Mil) to Dec. 2018 ($-27.22 Mil).

OWC Pharmaceutical Research  (OTCPK:OWCP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

OWC Pharmaceutical Research Retained Earnings Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research Retained Earnings Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Retained Earnings
Get a 7-Day Free Trial Premium Member Only -5.89 -7.55 -9.96 -14.52 -27.22

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.14 -27.22 -29.28 -22.38 -23.43

OWC Pharmaceutical Research Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-23.43 Mil mean?
OWC Pharmaceutical Research (OWCP) has a Retained Earnings of $-23.43 Mil as of Sep. 2019. Retained earnings is the amount of net income not issued to shareholders. View historical data on OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's Retained Earnings too high?
OWC Pharmaceutical Research's current Retained Earnings is $-23.43 Mil.
How does OWC Pharmaceutical Research's Retained Earnings compare to PARNF and CANB?
OWC Pharmaceutical Research's Retained Earnings of $-23.43 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on OWC Pharmaceutical Research and its competitors. OWC Pharmaceutical Research's current Retained Earnings is $-23.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current Retained Earnings of $-23.43 Mil. The current Retained Earnings is $-23.43 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current Retained Earnings is $-23.43 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.